All articles
Building muscle and burning fat – how it all fits together
Many people who want to lose weight and build muscle focus mainly on the number on the scales. However, losing weight does not always mean losing fat. The body is made up of muscle, fat, water, and bone, so changes in weight can be caused by several different factors. To understand how you can build muscle and burn fat, you need to know how your body uses energy and what influences your calorie expenditure over time.
Testosterone, Obesity and Men's Health: Role, Health Impact, and Treatment Options
Obesity significantly impacts men’s hormonal health — particularly testosterone — increasing risks of fatigue, weight gain, and chronic disease; understanding this connection is key to effective treatment and long-term wellbeing.
Understanding the Far-Reaching Risks of Obesity in Men: A Comprehensive Overview
Obesity in men is more than a weight issue — it’s a complex medical condition with far-reaching health risks. From heart disease and liver problems to hormonal and psychological effects, understanding these connections is key to effective prevention and management.
Talking About Weight Loss With a Loved One
Conversations about weight with loved ones can be sensitive because they often carry stigma and personal emotions, making even well-intended concern feel like judgment. When approached with empathy, however, these talks can strengthen trust and encourage healthier habits.
Sustainable Weight Loss and Health Benefits in Obesity Care: 18-Month Real-World-Evaluation Results in a Virtual Care Setting from Yazens First Operational Quality follow-up
This 18-month real-world evaluation data analysis demonstrates that Yazen Health’s fully digital care model, integrating pharmacological treatment and lifestyle intervention can provide effective, sustainable results in a real-world setting.
Summary
Patients achieved a weight reduction of 16.6%, accompanied by improvements in metabolic health markers including laboratory values, despite medication supply limitations and without using the maximum recommended dose of semaglutide. 70% remained in the program after 12 months. Weight loss outcomes were comparable to those observed in RCTs such as the STEP trials1-2.
High Adherence to GLP-1 Receptor Agonists: 18-Month Outcomes from the Yazen Model
High adherence rates to GLP-1 receptor agonists within a structured, digitally based weight management programme, may contribute to improved long-term medication adherence.
Summary
This real-world analysis from Yazens first large scale operational quality follow-up, demonstrates almost 70% compliance with GLP-1 medications at 12 months, surpassing earlier studies that showed 20-50%1-4. After 2 years*, 60% of patients were still in treatment.
The Yazen Model - Modern Obesity Treatment Given Via a Digital Care Model. A Descriptive Analysis
The Yazen Model enables modern obesity treatment, integrating medical treatment, lifestyle intervention and social support. By now*, more than 30,000 patients have received treatment using this model.
Summary
The Yazen Model goes beyond traditional methods, providing patients with the tools to manage their disease, addressing medical and behavioural aspects, education and social support via a digital platform for accessible, continuous and effective weight loss and management.













.webp)




.webp)
.webp)




